Left Menu
Development News Edition

BRIEF-Gilead requests FDA pull orphan drug designation from potential coronavirus drug

Reuters | Updated: 25-03-2020 23:26 IST | Created: 25-03-2020 23:08 IST
BRIEF-Gilead requests FDA pull orphan drug designation from potential coronavirus drug
Representative image Image Credit: Flickr / GileadSciences

Gilead Sciences Inc: * Says requested the U.S. FDA rescind the orphan drug designation it was granted for potential coronavirus drug remdesivir

* Says waiving all benefits that accompany orphan drug designation for remdesivir * Says confident that it can maintain an expedited timeline in seeking regulatory review of remdesivir Further company coverage:

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)

Download The Devdiscourse News App for Latest News.



Ayurveda for COVID 19: Professionals owe the responsibility to protect it from quacks and fake news

Indian Ayurveda professionals are lagging behind their foreign counterparts in handling quacks and protecting credentials of the Ayurveda at the time of COVID 19 pandemic. The professionals of Ayurveda cannot abjure the responsibility to co...

Education post-coronavirus: Schools to rush for more digitalization

Digital education would undoubtedly boom in the post-coronavirus world, supported by educational institutions that have discovered its efficiency during the crisis, but it is still not expected to outshine traditional classroom learning....

Public health care post-COVID 19 to go for revamping, not rebooting

Until now, the economies used to classify healthcare sector under social expenditure. However, the devastation caused by COVID 19 pandemic has upgraded public healthcare on topmost priority and core economic activity for controlling future ...

Coronavirus lockdowns to speed up long-pending revamping of supply chains

With millions of production lines impacted, business disruptions to some extent are unavoidable and the lessons learned from this turbulence will leave an everlasting impact on both global and local levels of supply chains....


Latest News

LIC contributes Rs 105 crore towards PM-CARES Fund

Life Insurance Corporation of India LIC on Tuesday said it has contributed Rs 105 crore towards the PM-CARES Fund to help the government fight the coronavirus pandemic. Out of the Rs 105 crore, Rs 5 crore has been donated from LICs Golden J...

Draegerwerk builds U.S. plant to fill respirator mask order

German medical equipment maker Draegerwerk said it would build a production site on the U.S. east coast to fill a government order for N95-type respirator masks, a key piece of protective equipment for healthcare workers battling the corona...

Paris to transfer 38 coronavirus patients to other regions on Wednesday - officials

Paris health officials will begin transferring 38 critical coronavirus patients by high-speed train from the Paris to regions that have been less overwhelmed to ease pressure on the capitals intensive care capacity, officials said on Tuesda...

Coronavirus: SC asks Centre to prevent migration, set up portal within 24 hrs for real time info

The Supreme Court asked the Centre on Tuesday to prevent migration of people due to coronavirus and set up within 24 hours a portal for disseminating real-time information on the pandemic to counter the panic being spread through fake news....

Give Feedback